Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 12;17(1):74.
doi: 10.1186/s13065-023-00983-6.

Earth-friendly micellar UPLC technique for determination of four hypoglycemic drugs in different pharmaceutical dosage forms and spiked human plasma

Affiliations

Earth-friendly micellar UPLC technique for determination of four hypoglycemic drugs in different pharmaceutical dosage forms and spiked human plasma

Manal S Elmasry et al. BMC Chem. .

Abstract

A novel, sensitive, and green micellar UPLC method was proposed and validated for the simultaneous determination of four hypoglycemic agents used in type II diabetes mellitus treatment namely, pioglitazone, alogliptin, glimepiride, and vildagliptin. The developed UPLC method was successfully applied for quantitative analysis of these drugs in bulk, in pharmaceutical formulations, and in spiked human plasma. Chromatographic separation was carried out on a Kinetex® 1.7 μm XB-C18 100 Å (50 × 2.1 mm) column, using a degassed and filtered mixture of (0.1 M SDS- 0.3% triethyl amine- 0.1% phosphoric acid (pH 6)) and n-propanol (85:15 v/v), at a flow rate of 0.2 mL/min. The experimental conditions of the suggested method were well investigated and optimized. The newly developed micellar UPLC method is capable of determining different dosage forms at the same time with the same solvents, saving time and effort. The method was found to be efficiently applicable in spiked human plasma and could be extended to study the pharmacokinetics of the cited drugs in real human plasma samples. The greenness of the developed method was evaluated by applying the Eco-scale scoring tool, which verified the excellent greenness of the analytical method.

Keywords: Alogliptin; Glimepiride; Micellar UPLC; Pioglitazone; Spiked human plasma; Vildagliptin..

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Chemical structure of (a) Pioglitazone, (b) Glimepiride, (c) Alogliptin, and (d) Vildagliptin
Fig. 2
Fig. 2
MUPLC chromatograms showing separation (20 µg/mL) of each PIO (Rt = 2.05 min), ALO (Rt = 4.62 min), GLM (Rt = 6.16 min), and VLD (Rt = 7.35 min) using the specified chromatographic conditions
Fig. 3
Fig. 3
MUPLC chromatograms of PIO (Rt = 2.05 min), and ALO (Rt = 4.62 min) in (a) Binary mixture (25:25 µg/mL) (b) Spiked plasma (25:25 µg/mL)
Fig. 4
Fig. 4
MUPLC chromatograms of PIO (Rt = 2.05 min), and GLM (Rt = 6.16 min) in (a) Binary mixture (25:25 µg/mL) (b) Spiked plasma (25:25 µg/mL)
Fig. 5
Fig. 5
MUPLC chromatograms of GLM (Rt =6.16 min) and VLD (Rt =7.35 min) in (a) Binary mixture (25:25 µg/mL) (b) Spiked plasma (25:25 µg/mL)
Fig. 6
Fig. 6
MUPLC chromatograms of PIO (Rt = 2.05 min), and VLD (Rt=7.35 min) in (a) Binary mixture (25:25 µg/mL) (b) Spiked plasma (25:25 µg/mL)

Similar articles

References

    1. Bastaki S. Diabetes mellitus and its treatment. Dubai Diabetes and Endocrinology Journal. 2005;13:111–34.
    1. Marín-Peñalver JJ, Martín-Timón I, Sevillano-Collantes C. del Cañizo-Gómez, Update on the treatment of type 2 diabetes mellitus. World J Diabetes. 2016;7:354–95. doi: 10.4239/wjd.v7.i17.354. - DOI - PMC - PubMed
    1. Krentz AJ, Patel MB, Bailey CJ. New drugs for type 2 diabetes mellitus. Drugs. 2008;68:2131–62. doi: 10.2165/00003495-200868150-00005. - DOI - PubMed
    1. The United States pharmacopeia . National formulary. Rockville (MD): United States Pharmacopeial Convention; 2021.
    1. Smith U. Pioglitazone: mechanism of action. Int J Clin Pract Suppl. 2001;121:13–8. - PubMed

LinkOut - more resources